Long-Acting Amylin Agonist AZD6234 AZD6234 is a novel long-acting selective AMY3R agonist developed by AstraZeneca for SC administration, and is currently in phase 2 testing [114]
Diabetes (2011) 60(4):124657
Track your pen, your dose level, and your injection site so you always know exactly where you are in your treatment
Though they've been around for a while, GLP-1 drugs also called GLP-1 agonists, incretin mimetics, or GLP-1 analogs have recently gotten more popular as medications that can help you manage your blood sugar and lose weight
BPC-157 and TB-500 are often discussed together because they may support different parts of soft-tissue recovery
Although NAION can strike without warning, regular comprehensive eye examinations with your optometrist or ophthalmologist still serve important purposes